Differences

This shows you the differences between two versions of the page.

--- home:diseases:cancer [05.16.2019] – [Other Immune Suppressants] sallieq
+++ home:diseases:cancer [06.12.2019] – [Recent research] sallieq
@@ Line 385: / Line 385: @@
 In this large population-based gastro-oesophageal cancer cohort, we found moderately reduced cancer-specific mortality among ARB users. However, confirmation in further independent epidemiological studies with sufficient staging information is required.  (({{pubmed>long:29105106}}))
-miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan.  (({{pubmed>long:    28304186}}))
+miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan.  (({{pubmed>long:28304186}}))
 Therapeutic potentials of SCFA receptors [section 7 in   (({{pubmed>long:27113407}})) ]
 Recent progress in understanding the role of GPR41, GPR43 and GPR109A in health and disease demonstrate that these receptors do not just regulate inflammation and cancer in intestine, but also influence other gastrointestinal functions, allergies, adipogenesis, central nervous system and cardiovascular health.
+ review current evidence on the role of the human microbiota in four cancer types (colorectal cancer, head and neck cancer, pancreatic cancer, and lung cancer) proposed as affected by both the oral and gut microbiota (({{pubmed>long:28822617}}))
+ results suggest that the six lactic acid bacteria mixture from kefir has strong effects on natural immunity and tumor cell cytotoxicity(({{pubmed>long:29584690}}))
+ Using metabolomics, we investigated the metabolic influence that microbial biofilms have on colon tissues and the related occurrence of cancer.(({{pubmed>long:25959674}}))

home/diseases/cancer.txt · Last modified: 09.14.2022 by 127.0.0.1